Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fortichem is a multivitamin and multimineral combination product developed and marketed by Corporación Farmayala (through its division INDEUREC) in Ecuador. It is formulated as an oral supplement to prevent and treat nutritional deficiencies resulting from inadequate diet, increased physical or mental demand, or recovery from illness. The product contains a comprehensive blend of essential vitamins, including the B-complex (B1, B2, B6, B12, nicotinamide, pantothenate, and folic acid), fat-soluble vitamins (A, D3, and E), and vitamin C, alongside vital minerals such as iron, zinc, magnesium, and calcium. These components act as essential cofactors in numerous metabolic pathways, support immune function, and contribute to the maintenance of bone and hematological health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fortichem.